Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00801827 · ClinicalTrials.gov registry record · Phase 1
PET Imaging and Bariatric Surgery
A Phase 1 study of Obesity, Morbid, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT00801827: Completed Phase 1 study of Obesity, Morbid, sponsored by Vanderbilt University Medical Center.
NCT00801827 is a Phase 1 study of Obesity, Morbid that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 7 participants, below the 103-participant average among 19 other Obesity, Morbid trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00801827, a Phase 1 study of Obesity, Morbid, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to look at certain areas of the brain that are related to addictive behaviors, such as overeating. These areas are called 'dopamine type 2 receptors' (DRD2/3) and other studies have shown that obese people have less of these. We propose that low DRD2/3 availability seen in morbidly obese subjects will change with weight loss associated with bariatric surgery.
Conditions Studied
Interventions
- DRUG F-18 (fallypride)
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2007-01 |
| Est. Completion | 2012-06 |
| Phase | Phase 1 |
What the finished NCT00801827 record still lists
NCT00801827 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 103-participant average among 19 other Obesity, Morbid trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Obesity, Morbid appearing as the primary indexed condition, and to 1 intervention - of which F-18 (fallypride) is the first listed.
NCT00801827 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00801827 about?
NCT00801827 is a clinical study titled "PET Imaging and Bariatric Surgery". The purpose of this study is to look at certain areas of the brain that are related to addictive behaviors, such as overeating. These areas are called 'dopamine type 2 receptors' (DRD2/3) and other studies have shown that obese people have less of these. We propose that low DRD2/3 availability seen ...
What is the current status of trial NCT00801827?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2007-01. Estimated completion is 2012-06.
What conditions does trial NCT00801827 study?
This clinical trial studies the following conditions: Obesity, Morbid.
What interventions are being tested in trial NCT00801827?
The interventions under investigation include: F-18 (fallypride) (DRUG).
Who is sponsoring clinical trial NCT00801827?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00801827 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity, Morbid
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00801827's enrollment target sits among peer trials
7 18th of 19 higher than 2 of 19 other Obesity, Morbid trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity, Morbid trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
RECRUITING
-
Trans-nasal Endoscopy for Bariatric Patients
RECRUITING · NA
-
Time-restricted Eating Among Pregnant Females With Severe Obesity
RECRUITING · NA
-
Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues
RECRUITING · Early Phase 1
-
Efficacy and Safety of Endoscopic Antral Myotomy as a Novel Weight Loss Procedure
RECRUITING
-
Long-term, Substantial Weight Loss and Insulin Regulation of Lipolysis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia